Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics
CINCINNATI, June 06, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc. is providing the following clarifying comments on the FDA’s recent recall notice posting. On May 17, 2017 Meridian Bioscience, Inc. commented that its subsidiary, Magellan Diagnostics, was working closely with the U.S. Food and Drug Administration (FDA) regarding the use of […]